PLATINUM EQUITY GROUP acquires SUNRISE MEDICAL (2024)

Deal facts

Buyer: PLATINUM EQUITY GROUP
Target: SUNRISE MEDICAL
Deal value: Not disclosed
Announced: 28 July 2024
Status: In review
Sector: Healthcare
Country: Not stated
Consideration: Not stated

Sources

EU_DG_COMP

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

20 Aug 2024CMA invitation to comment
PLATINUM EQUITY GROUP / SUNRISE MEDICAL
PLATINUM EQUITY GROUP / SUNRISE MEDICAL
EU DG COMP

OpinionExit Mode editorial

We see a clear signal in the announcement that Platinum Equity Group has agreed to acquire Sunrise Medical. This transaction, dated 28 July 2024, places a major private equity firm into the healthcare sector with a specific focus on mobility and rehabilitation equipment. The deal remains in review, which is the standard procedural step for such a transfer of control. For the SME founder watching from the sidelines, this highlights how institutional capital continues to seek out established players in essential services where cash flow is predictable and market position is defensible.

The involvement of a private equity buyer like Platinum Equity Group suggests a strategy focused on operational consolidation rather than a simple financial flip. In the healthcare space, this often means the new owners will look to streamline supply chains or expand distribution networks across existing territories. Because the deal is still in review, regulatory clearance is the immediate hurdle. While the Competition and Markets Authority does not always intervene in every healthcare transaction, the sector attracts close scrutiny regarding market concentration. The buyer must navigate these competition checks to ensure the acquisition does not unfairly limit consumer choice or raise prices for patients.

We think the structural mechanics of this deal will likely include standard protections for the seller and the business. Given the nature of private equity acquisitions, founders should expect earn-out provisions tied to future performance targets or escrow arrangements to cover potential indemnity claims. These are not mere formalities but critical levers that determine the final cash received at completion. The lack of a disclosed value in the announcement is common at this stage, but it does not diminish the strategic weight of the move. The focus now shifts to how the new ownership integrates Sunrise Medical into its broader portfolio without disrupting the core service to customers.

The immediate action for any founder in a similar position is to map out your change-of-control covenants before engaging with potential buyers. Review your customer contracts, supplier agreements, and employee terms to identify any clauses that trigger automatic termination or require third-party consent upon a sale. If you are considering a future exit, you must know which relationships could break if ownership changes, as this directly impacts deal certainty and valuation. Address these risks now, not during the due diligence phase when leverage is lowest.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2024 deals More pe acquisition deals More from PLATINUM EQUITY GROUP All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

16 April 2026Firm intentionHealthcare

CCP PAW 2 LIMITED to acquire Animalcare Group plc

CCP PAW 2 LIMITED has agreed to acquire Animalcare Group plc in a private equity acquisition valued at 235.2 million GBP. The transaction, announced on 16 April 2026, in…

Buyer: CCP PAW 2 LIMITED
Target: Animalcare Group plc
Deal value: GBP 235,200,000
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals United Kingdom deals

22 January 2026In reviewHealthcare

BLACKSTONE / TPG to acquire HOLOGIC

BLACKSTONE / TPG and HOLOGIC entered the Exit Mode archive.

Buyer: BLACKSTONE / TPG
Target: HOLOGIC
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

3 September 2025In reviewHealthcare

BAIN CAPITAL / KOHLBERG to acquire PCI PHARMA GROUP

BAIN CAPITAL / KOHLBERG and PCI PHARMA GROUP entered the Exit Mode archive.

Buyer: BAIN CAPITAL / KOHLBERG
Target: PCI PHARMA GROUP
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

9 July 2025In reviewHealthcare

KKR to acquire KARO HEALTHCARE

KKR has agreed to acquire KARO HEALTHCARE in a private equity acquisition. The transaction was announced on 9 July 2025. The target operates within the NaceV2Sector_N_72…

Buyer: KKR
Target: KARO HEALTHCARE
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

11 May 2025In reviewHealthcare

HELLMAN & FRIEDMAN / CVC to acquire MEHILÄINEN

Hellman & Friedman and CVC have agreed to acquire Mehiläinen, a Finnish healthcare provider, in a private equity acquisition announced on 11 May 2025. The transaction in…

Buyer: HELLMAN & FRIEDMAN / CVC
Target: MEHILÄINEN
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals Finland deals

Buyer history